196 related articles for article (PubMed ID: 918461)
1. [Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
Baldy-Moulinier M; Bories P; Michel H; Passouant P
Rev Neurol (Paris); 1977 Mar; 133(3):175-89. PubMed ID: 918461
[TBL] [Abstract][Full Text] [Related]
2. Brain energy metabolism in hepatic coma.
Maiolo AT; Porro GB; Galli C; Sessa M; Polli EE
Exp Biol Med; 1971; 4():52-70. PubMed ID: 5162460
[No Abstract] [Full Text] [Related]
3. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
[TBL] [Abstract][Full Text] [Related]
5. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.
Ahl B; Weissenborn K; van den Hoff J; Fischer-Wasels D; Köstler H; Hecker H; Burchert W
Hepatology; 2004 Jul; 40(1):73-9. PubMed ID: 15239088
[TBL] [Abstract][Full Text] [Related]
7. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation.
Philips BJ; Armstrong IR; Pollock A; Lee A
Hepatology; 1998 Feb; 27(2):369-76. PubMed ID: 9462633
[TBL] [Abstract][Full Text] [Related]
8. [Heterologous pig liver perfusion in hepatic coma].
Flatmark A; Aune S; Otnes B; Nesbakken R; Ro J; Schistad G; Lie M; Raeder M; Jakobsen A; Skulberg P; Lilleaasen P; Gjone E
Tidsskr Nor Laegeforen; 1969 Jun; 89(11):809-13. PubMed ID: 5793594
[No Abstract] [Full Text] [Related]
9. CBF and metabolism in hepatic encephalopathy: effects of acute hyperammoneamia and of L. dopa.
Baldy-Moulinier M; Bories P
Acta Neurol Scand Suppl; 1977; 64():348-9. PubMed ID: 268830
[No Abstract] [Full Text] [Related]
10. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.
Keiding S; Pavese N
Arch Biochem Biophys; 2013 Aug; 536(2):131-42. PubMed ID: 23726863
[TBL] [Abstract][Full Text] [Related]
11. Partial pressure of ammonia versus ammonia in hepatic encephalopathy.
Kramer L; Tribl B; Gendo A; Zauner C; Schneider B; Ferenci P; Madl C
Hepatology; 2000 Jan; 31(1):30-4. PubMed ID: 10613724
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic circulation and metabolism in patients with acute liver failure.
Clemmesen O
Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280
[TBL] [Abstract][Full Text] [Related]
14. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study.
Aggarwal S; Kramer D; Yonas H; Obrist W; Kang Y; Martin M; Policare R
Hepatology; 1994 Jan; 19(1):80-7. PubMed ID: 8276371
[TBL] [Abstract][Full Text] [Related]
15. Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy.
Iversen P; Sørensen M; Bak LK; Waagepetersen HS; Vafaee MS; Borghammer P; Mouridsen K; Jensen SB; Vilstrup H; Schousboe A; Ott P; Gjedde A; Keiding S
Gastroenterology; 2009 Mar; 136(3):863-71. PubMed ID: 19041869
[TBL] [Abstract][Full Text] [Related]
16. Partial pressure of NH₃ in cirrhotic patients with and without hepatic encephalopathy.
He Y; Li G; Song H; Luo T; Gao B; Xu J
J Gastrointestin Liver Dis; 2011 Jun; 20(2):169-74. PubMed ID: 21725514
[TBL] [Abstract][Full Text] [Related]
17. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.
Lockwood AH; Yap EW; Wong WH
J Cereb Blood Flow Metab; 1991 Mar; 11(2):337-41. PubMed ID: 1997506
[TBL] [Abstract][Full Text] [Related]
18. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
19. Metabolic encephalopathy: mechanisms affecting limbic function.
Lockwood AH
Tohoku J Exp Med; 1990 Aug; 161 Suppl():203-11. PubMed ID: 1964512
[TBL] [Abstract][Full Text] [Related]
20. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
